Arijit Sinha

Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

Othman Al‐Sawaf, Can Zhang, Maneesh Tandon et al. · The Lancet Oncology · 2020 · 319 citations

Hematological Malignancy, Lymphoid Neoplasia, Chronic Lymphocytic Leukaemia +14

Synthesis of hydroxyapatite from Lates calcarifer fish bone for biomedical applications

Anindya Pal, Sudeep Paul, Amit Roy Choudhury et al. · Materials Letters · 2017 · 158 citations

Tissue Engineering, Engineering, Fish Bone +9

A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma

Franck Morschhauser, Pierre Feugier, Ian W. Flinn et al. · Blood · 2020 · 158 citations · Full text

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial

Andrew D. Zelenetz, Gilles Salles, Kylie D. Mason et al. · Blood · 2019 · 133 citations · Full text

Mesoporous CuO–ZnO p–n heterojunction based nanocomposites with high specific surface area for enhanced photocatalysis and electrochemical sensing

Sumit Chabri, Arnab Dhara, Bibhutibhushan Show et al. · Catalysis Science & Technology · 2015 · 129 citations

Materials Science, Solid State Reactions, Copper Oxide Materials +13